Saving lives, one heart at a time

A Picard Medical Company

0+ implants 

0+ countries 

0 sizes 

An Essential Tool for End-Stage Heart Failure


The SynCardia Total Artificial Heart (STAH) is a clinically proven life-saving treatment option for cardiac transplant-eligible patients at risk of imminent death from biventricular heart failure.

When a donor heart isn’t available and an LVAD isn’t enough, the SynCardia Total Artificial Heart can give patients with end-stage biventricular heart failure the priceless gift of more time as a bridge to heart transplant.

0+ patient years of support

 

Experience the SynCardia

Product Briefing


Watch our latest Product Briefing, held in San Francisco, to explore our vision, mission, and unwavering commitment to advancing total artificial heart technology.


This video features insights from our executive team, and leading clinicians who support us on this incredible journey. Most importantly, hear from a patient and leader of Unique Beating Hearts, a nonprofit dedicated to supporting total artificial heart patients.


Join us in shaping the future of heart failure treatment.

LATEST NEWS

You can find the latest news, press releases, and event updates from SynCardia and Picard Medical at the links below.

SynCardia is Here to Help

Interested in learning more about the SynCardia Total Artificial Heart or in establishing a SynCardia Total Artificial Heart program at your hospital? 


SynCardia’s products are approved for sale in the United States and Canada. 

”Freedom” is a registered trademark of SynCardia Systems, LLC. “SynCardia Systems”, the SynCardia logo, “Giving the Gift of Time”, “Saving Lives, one Heart at a Time”, “Companion 2 Driver ” are trademarks of SynCardia Systems, LLC. 

SynCardia Systems, LLC

1992 E. Silverlake Rd. Tucson, AZ 85713 | US
+1 520-545-1234 | info@syncardia.com
www.SynCardia.com

SynCardia Systems, LLC – a Picard Medical Company

The SynCardia Total Artificial Heart (STAH) is a treatment option for cardiac transplant-eligible patients at risk of imminent death from biventricular failure.

Medical Advice Disclaimer
The information, including but not limited to, text, graphics, images, and other components contained in this material are for informational purposes only. No information in this material is intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or a qualified health care provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of information you have read in this material.


SynCardia's products are approved for sale in the U.S. and Canada only.

SynCarida Systems, LLC is a wholly owned subsidiary of Picard Medical Inc. © SynCardia Systems, LLC. All rights reserved.

This website makes use of cookies. Please see our Privacy & Cookie Policy for details.

Deny OK